Effects of Steps to Success Exercise Program in Weight Management For Psychiatric Patients Taking Atypical Antipsychotic Drugs

Authors

  • Homelo V. Estoque Far Eastern University

DOI:

https://doi.org/10.30994/jnp.v4i1.112

Keywords:

Atypical Antipsychotic Drugs, Induced Weight Gain, Exercise Program, Schizophrenia, Bipolar

Abstract

Background: Patients taking atypical antipsychotics are in danger of antipsychotic-induced weight gain. Weight increases rapidly in the initial period after starting antipsychotics. Cardiovascular and cerebrovascular morbidity and mortality and reduced quality of. Both nonpharmacologic prevention and intervention strategies have shown modest effects on weight. Changes in physical appearance can lead to body image issues and problems with self-esteem, which in turn could lead to poor compliance with medication.   
Purpose: This study aimed to evaluate the effectiveness of an exercise program that can benefit patients who are gaining weight related to atypical antipsychotic agent intake.
Methods: A quasi-experimental research design was undertaken. The research setting was held in a general tertiary medical teaching/training medical facility owned by the Philippine government. There are 31 respondents for this study 12 were males and 19 were females who were chosen from the list of the in-patients utilizing the universal sampling technique. Data were gathered using a self-formulated tool to collect mostly demographic data which is adopted from the National Alliance for Mental Health.
Results: Patients’ diagnosis tends to have a positive relationship with weight loss. Respondents diagnosed with bipolar with psychotic features showed to have loss weight more than the diagnosed with schizophrenia. The results of this study showed that patient’s adhering to the exercise program had lost weight after the course. 
Conclusion: Activity and exercise are especially important for people living with mental illness. Furthermore, physical activity does not only help patients manage their weight but to serve as diversional activity that adds vitality for patients in the facility

Downloads

Download data is not yet available.

References

About Mental Illness - National Alliance on Mental Illness - Iowa, Inc. - National Alliance on Mental Illness – Iowa, Inc. (n.d.). Retrieved June 23, 2020, Retrieved from Article

Camelo, E. V. M., Velasques, B., Ribeiro, P., Netto, T., & Cheniaux, E. (2013). Attention impairment in bipolar disorder: A systematic review. Psychology and Neuroscience, 6(3), 299–309. Crossref

Chaput, J., Saindon, J., Gauthier, Y., Lancto, G., Vincent, A., Gagnon, S., & Tremblay, A. (2008). May, 1–11. Crossref

Das, C., Mendez, G., Jagasia, S., & Labbate, L. (2012). Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-analysis of behavioral and pharmacologic treatments. Annals of Clinical Psychiatry?: Official Journal of the American Academy of Clinical Psychiatrists, 24, 225–239. Retrieved from Article

Daumit, G. L., Dickerson, F. B., Wang, N. Y., Dalcin, A., Jerome, G. J., Anderson, C. A. M., Young, D. R., Frick, K. D., Yu, A., Gennusa, J. V., Oefinger, M., Crum, R. M., Charleston, J., Casagrande, S. S., Guallar, E., Goldberg, R. W., Campbell, L. M., & Appel, L. J. (2013). A behavioral weight-loss intervention in persons with serious mental illness. New England Journal of Medicine, 368(17), 1594–1602. Crossref

Dayabandara, M., Hanwella, R., Ratnatunga, S., Seneviratne, S., Suraweera, C., & de Silva, V. A. (2017a). Antipsychotic-associated weight gain: Management strategies and impact on treatment adherence. Neuropsychiatric Disease and Treatment, 13, 2231–2241. Crossref

Dayabandara, M., Hanwella, R., Ratnatunga, S., Seneviratne, S., Suraweera, C., & de Silva, V. A. (2017b). Antipsychotic-associated weight gain: Management strategies and impact on treatment adherence. In Neuropsychiatric Disease and Treatment (Vol. 13, pp. 2231–2241). Dove Medical Press Ltd. Crossref

Eapen, V., & John, G. (2011). Weight gain and metabolic syndrome among young patients on antipsychotic medication: What do we know and where do we go? Australasian Psychiatry, 19(3), 232–235. Crossref

Edenfield, T. M. (2008). Exercise and mood: Exploring the role of exercise in regulating stress reactivity in bipolar disorder. Dissertation Abstracts International: Section B: The Sciences and Engineering, 68(8-B), 5566. Retrieved from Article

Every-Palmer, S., Huthwaite, M. A., Elmslie, J. L., Grant, E., & Romans, S. E. (2018). Long-term psychiatric inpatients’ perspectives on weight gain, body satisfaction, diet and physical activity: A mixed methods study 11 Medical and Health Sciences 1117 Public Health and Health Services. BMC Psychiatry, 18(1), 1–10. Crossref

Faulkner, G., Cohn, T., & Remington, G. (2007). Interventions to reduce weight gain in schizophrenia. Cochrane Database of Systematic Reviews, 1, 1–163. Crossref

Feldmann, T. B. (2001). Bipolar disorder and violence. Psychiatric Quarterly, 72(2), 119–129. Crossref

Foy, C. G., Rejeski, W. J., Berry, M. J., Zaccaro, D., & Woodard, C. M. (2001). Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest, 119(1), 70–76. Crossref

Garno, J. L., Gunawardane, N., & Goldberg, J. F. (2008). Predictors of trait aggression in bipolar disorder. Bipolar Disorders, 10(2), 285–292. Crossref

Gilbody, S., Bagnall, A. M., Duggan, L., & Tuunainen, A. (2016). Risperidone versus other atypical antipsychotic medication for schizophrenia. Cochrane Database of Systematic Reviews, 2016(9), 2–5. Crossref

Gunnell, D., & Harbord, R. M. (2003). Better or worse: a longitudinal study of the mental health of adults living in private households in Great Britain. Semantic Scholar. Retrieved from Article

Hampton, J. N., Trotman, H. D., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Tsuang, M. T., Perkins, D. O., Seidman, L. J., Woods, S. W., & Walker, E. F. (2018). The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress and Health, 34(5), 591–600. Crossref

Malhi, G. S., Mitchell, P. B., & Caterson, I. (2001). Why getting fat, Doc? Weight gain and psychotropic medications. Australian and New Zealand Journal of Psychiatry, 35(3), 315–321. Crossref

Manderscheid, R. W., Ryff, C. D., Freeman, E. J., McKnight-Eily, L. R., Dhingra, S., & Strine, T. W. (2010). Evolving definitions of mental illness and wellness. Preventing Chronic Disease, 7(1). Retrieved from Article

Martínez-Ortega, J. M., Funes-Godoy, S., Díaz-Atienza, F., Gutiérrez-Rojas, L., Pérez-Costillas, L., & Gurpegui, M. (2013). Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: A critical review. European Child and Adolescent Psychiatry, 22(8), 457–479. Crossref

Miller, W. C., Koceja, D. M., & Hamilton, E. J. (1997). A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. International Journal of Obesity, 21(10), 941–947. Crossref

Naslund, J. A., Whiteman, K. L., McHugo, G. J., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2017). Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis. In General Hospital Psychiatry (Vol. 47, pp. 83–102). Elsevier Inc. Crossref

Niv, N., Cohen, A. N., Hamilton, A., Reist, C., & Young, A. S. (2014). Effectiveness of a psychosocial weight management program for individuals with schizophrenia. Journal of Behavioral Health Services and Research, 41(3), 370–380. Crossref

Poulin, M. J., Chaput, J. P., Simard, V., Vincent, P., Bernier, J., Gauthier, Y., Lanctôt, G., Saindon, J., Vincent, A., Gagnon, S., & Tremblay, A. (2007). Management of antipsychotic-incluced weight gain: Prospective naturalistic study of the effectiveness of a supervised exercise programme. Australian and New Zealand Journal of Psychiatry, 41(12), 980–989. Crossref

Vaillant, G. E. (2003). Mental Health. American Journal of Psychiatry, 160(8), 1373–1384. Crossref

Vreeland, B., Minsky, S., Menza, M., Radler, D. R., Roemheld-Hamm, B., & Stern, R. (2003). A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services, 54(8), 1155–1157. Crossref

Werneke, U., Taylor, D., & Sanders, T. A. B. (2013). Behavioral interventions for antipsychotic induced appetite changes. Current Psychiatry Reports, 15(3). Crossref

Woo, J. S., Derleth, C., Stratton, J. R., & Levy, W. C. (2006). The influence of age, gender, and training on exercise efficiency. Journal of the American College of Cardiology, 47(5), 1049–1057. Crossref

Wood, B. J. (2013). People With Serious Mental Illness Can Lose Weight , Too. 1–3.

Downloads

Published

2020-10-10

How to Cite

Estoque, H. V. (2020). Effects of Steps to Success Exercise Program in Weight Management For Psychiatric Patients Taking Atypical Antipsychotic Drugs. Journal Of Nursing Practice, 4(1), 84–96. https://doi.org/10.30994/jnp.v4i1.112

Issue

Section

Articles